Atlas Trials

A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS

Clinical trial NCT06020833 · WITHDRAWN

Trial details

NCT number
NCT06020833
Sponsor
Peking Union Medical College Hospital
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2023-08-01
Primary completion
2025-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.